Haystack Oncology was founded to dramatically improve patient outcomes with transformative precision oncology.What You Should Know:Quest Diagnostics has reached an agreement to acquire Haystack Oncology an early-stage oncology company focused on minimal residual disease (MRD) testing to aid…
Continue Reading
The University of Virginia (UVA) School of Medicine has launched the Center for Health Equity and Precision Public Health to improve health outcomes for minority populations, those in economically challenged areas, and rural communities…
Continue Reading
CHICAGO — Implementing precision medicine programs could allow health systems to diagnose disease more quickly or predict a patient’s response to a specific mediation, said panelists at the 2023 HIMSS Global Health Conference &…
Continue Reading
Virtual integrated care platform Recuro Health announced it closed a $47 million Series B financing round. ARCH Venture Partners, the Flippen Group, GPG Ventures, 4D Capital and other investors participated in the raise.
WHAT THEY DO
Recuro…
Dr. Nathalie Johnson, MD FACS and President of The American Society of Breast Cancer SurgeonsWhat You Should Know:– A recent study published in JAMA found that conventional genomic tests commonly used for breast cancer…
Continue Reading
What You Should Know:– NVIDIA today announced an expanded set of generative AI cloud services for customizing AI foundation models to accelerate the creation of new proteins and therapeutics, as well as research in…
Continue Reading
Our latest roundup of contracts and go lives features sustainable tech company Jump winning an NHS England contract to develop a carbon engagement tool, and Worcestershire Acute Hospitals NHS Trust deploying Altera Digital Health’s…
Continue Reading
By Hannah Nelson
March 15, 2023 – The HL7 Fast Healthcare Interoperability Resources (FHIR) Accelerator CodeX has announced an expanded steering committee and new additions to its leadership team.
CodeX aims to advance the adoption…
Genomics England has competed the installation of Sectra’s enterprise imaging system, which will support the world’s largest multimodal cancer research platform.Sectra’s technology will play a key role in allowing Genomics England to bring together…
Continue Reading
Guilherme Macagnan, CEO, AMX HealthcareThe market demand for data-driven technology solutions in healthcare is on the rise. Today, one-third of the world’s data is generated by the healthcare industry. This data is often complex and is coming from multiple different sources such as personal health information, claims data, clinical trial data,…
Continue Reading
